Harmonising drug-target binding data analytics on a single platform

Supported by:

13 November 2018

Harmonizing drug-target binding data analytics on a single platform


In early stage medicines research, measuring in vitro drug-target interaction characteristics is a critical path activity in selecting therapeutic candidates for progression into pre-clinical models. Technologies and instrumentation used in this space are numerous. Bespoke instrument-specific data analysis software make the data handling and result-publishing workflow disjointed. It requires too many manual data handling steps leading to inefficiency and elevated risks to data integrity. In research scenarios such as this, efficient handling, processing and publishing of high volumes of experimental data is critical for objective decision making and selecting optimal therapeutic candidates.

This webinar outlined the fundamentals of a design process where an experimental analytics data workflow is being integrated into a more seamlessly interactive digital platform.


Thil BatuwangalaThil Batuwangala, Scientific Leader, Biopharma Molecular Discovery at GlaxoSmithKline

Thil has worked on therapeutic antibody R&D for 10+ years. He currently leads a team doing antibody target interaction characterisation & biophysical property profiling in GSK’s in-vitro & in-vivo antibody drug discovery program.

William J. YangWilliam J. Yang, Global Marketing Leader, Screening Portfolio at PerkinElmer

Starting as a Biogen researcher, Bill Yang went from the bench to business with Life Sciences sales & marketing roles. Before PerkinElmer, Bill held management positions at GE Healthcare, Life Technologies, CambridgeSoft, & Eli Lilly.

The rest of this content is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here